052670 — CHEIL BIO Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for CHEIL BIO Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	18,999	16,912	15,349	12,111	13,908
Cost of Revenue
Gross Profit	3,787	2,225	2,445	2,329	3,219
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	19,487	18,639	16,919	14,129	14,985
Operating Profit	-488	-1,726	-1,570	-2,018	-1,077
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,230	138	-1,756	-1,464	-411
Provision for Income Taxes
Net Income After Taxes	994	-712	-1,708	-1,446	-417
Net Income Before Extraordinary Items
Net Income	994	-712	-1,708	-1,446	-417
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	994	-712	-1,708	-1,446	-417
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	52,722	-37,815	-90,104	-79,817	-22,456
Dividends per Share